Abstracts tagged "Spondylarthropathy and uveitis"

Abstract Number: 1605 • 2018 ACR/ARHP Annual Meeting
Prevalence of Anterior Uveitis in Patients with Spondyloarthropathy in a Single US Academic Center: A Retrospective Study from Routine Care
Ofelya Gevorgyan¹, Rebecca D. Sarran², Pauline T. Merrill², Joel A. Block³ and Isabel Castrejon¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Ophthalmology, Rush University Medical Center, Chicago, IL, ³Division of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Acute anterior uveitis (AAU) is the most common extra-articular feature of spondyloarthropathies (SpA) over the course of the disease. Around 33% of patients with…
Abstract Number: 2779 • 2013 ACR/ARHP Annual Meeting
A Novel Evidence-Based Detection Of Undiagnosed Spondyloarthritis In Patients Presenting With Acute Anterior Uveitis: The DUET (Dublin Uveitis Evaluation Tool) Algorithm
Muhammad Haroon¹, Michael Anthony O'Rourke², Pathma Ramasamy², Conor Murphy² and Oliver FitzGerald¹, ¹Department of Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, ²Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland
Background/Purpose: The prevalence of mostly undiagnosed underlying Spondyloarthropathy (SpA) is more than 60% among patients presenting with acute anterior uveitis (AAU). To date, there are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].